ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCJohn J.V. McMurray, Stamatis Adamopoulos, Stefan D. Anker et al.|European Heart Journal|2012Cited by 6.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012Adam Torbicki, Alec Vahanian, Stephan Windecker et al.|European Journal of Heart Failure|2012Cited by 2.6k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or BothMarc A. Pfeffer, Robert M. Califf, John J.V. McMurray et al.|New England Journal of Medicine|2003Cited by 2.5k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary SyndromeMarc A. Pfeffer, Jean‐Claude Tardif, Brian Claggett et al.|New England Journal of Medicine|2015Cited by 2.3k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 DiabetesRury R. Holman, Adrian F. Hernandez, M. Angelyn Bethel et al.|New England Journal of Medicine|2017Cited by 2.1k